Visual Pathway Glioma — Trials

Visual Pathway Glioma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	completed	Phase 2	75	National Cancer Institute (NCI)NIH	4	Jan 7, 2025	clinicaltrials
NCT03326388	Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours(INSPECT)	completed	Phase 1 / Phase 2	14	Great Ormond Street Hospital for Children NHS Foundation TrustOTHER	1	Apr 4, 2024	clinicaltrials
NCT02839720	Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma	completed	Phase 2	11	National Cancer Institute (NCI)NIH	1	Dec 6, 2023	clinicaltrials

Data updated 22 days agoSource updated Jan 7, 2025source: clinicaltrials